Present, prevention, and management of chronic kidney disease in Latin America

Blood Purification

Volumn 26, Issue 1, 2008, Pages 90-94

  Correa Rotter, Ricardo ^a   Cusumano, Ana María ^b  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b CEMIC   (Argentina)

Author keywords

Chronic kidney disease, prevention; End stage renal disease; Renal replacement therapy

Indexed keywords

CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; ETHNICITY; HEALTH CARE; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; LIFE EXPECTANCY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PREVENTION AND CONTROL; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RENAL REPLACEMENT THERAPY; SOCIAL STATUS; SOCIOLOGY; SOUTH AND CENTRAL AMERICA; STATISTICAL SIGNIFICANCE;

DIABETES COMPLICATIONS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; LATIN AMERICA; PREVALENCE; RENAL REPLACEMENT THERAPY;

EID: 38049061127     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110572     Document Type: Conference Paper

References (21)

1. Kher V: End-stage renal disease in developing countries. Kidney Int 2002;62:350-362.
2. World Bank: World Development Report: Investing in Health. New York, Oxford University Press, 1993.
3. Murray CJL, Lopez AD: Global Comparative Assessments in the Health Sector. Geneva, WHO, 1994.
4. Instituto Nacional de Geografia e Informatica INEGI/DGEI, Dirección general de epidemiología, Secretaria de Salud, México 2000.
5. Correa-Rotter R: Renal replacement therapy in the developing world. Are we on the right track, or should there be a new paradigm? J Am Soc Nephrol 2007;18:1635-1636.
6. García-García G, Briseño-Rentería G, Gao Z, Luquín-Arellano V, Gill J, Tonelli M: Survival among patients with kidney failure in Jalisco, Mexico. J Am Soc Nephrol 2007;18:1922-1927.
7. CEPAL, Anuario estadístico de América Latina y el Caribe, 2005. Estadísticas sociales. Available at http://www.eclac.org/ publicaciones/xml/0/26530/LCG2311B_1.pdf. Accessed Sept 2, 2007.
8. World Development Indicator Database: World Bank, 2004, http://devdata.worldbank. org/data.
9. Registro Latinoamericano de Diálisis y Trasplante. Informe del año 2001. Nefrol Latinoam 2002;9:190-243.
10. Parving H-H: Diabetic nephropathy: prevention and treatment. Kidney Int 2001;60:2041-2055.
11. Wild S, Roglic G, Green A, Sicree R, King H: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
12. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, Rojas R, Villalpando-Hernández S, Hernández-Avila M, Sepúlveda-Amor J: Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, Available at http://www.insp.mx/ensanut/. Last accessed Sept 3, 2007.
13. Encuesta Nacional de Salud 2003 (ENS 2003). Available at: http://www.emol.com/noticias/documentos/informe_salud.pdf. Last accessed Sept 3, 2007.
14. Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM: Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int 2002;61:2165-2175.
15. Registro Latinoamericano de Diálisis y Trasplante Renal. Año 1991. Nefrol Latinoam 1994;1:89-99.
16. Cusumano A, Di Gioia C, Hermida O, et al: The Latin American Dialysis and Renal Transplantation Registry Annual Report 2002. Kidney Int 2005;68(suppl 97):S1-S7.
17. Cusumano A, Garcia Garcia G, Gonzalez C, et al: Registro Latinoamericano de Diálisis y Trasplante Renal Report. 2006, in press.
18. Burgess ED, Carides GW, Gerth WC, Marentette MA, Chabot I: Losartan reduces the costs associated with nephropathy and endstage renal disease from type 2 diabetes: economic evaluation of the RENAAL study from a Canadian perspective. Can J Cardiol 2004;20:613-618.
19. Palmer AJ, Annemans L, Roze S, Lamotte M, Rodby RA, Cordonnier DJ: An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings. Nephrol Dial Transplant 2003;18:2059-2066.
20. Gaede P, Vedel P, Larsen N, Jensen G, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;48:383-393.
21. Consejo Mexicano de Nefrología AC. Available from http://www.consejomexicanodenefrologia.com.mx, April 2007.